Exact Sciences
EXAS
#1767
Rank
C$13.25 B
Marketcap
$71.61
Share price
-3.29%
Change (1 day)
-13.16%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$0.21 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$2.61 Billion. In 2023 the company made an earning of -C$0.26 Billion, an increase over its 2022 earnings that were of -C$0.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.21 Billion-19.09%
2023 -C$0.26 Billion-69.98%
2022 -C$0.86 Billion-25.55%
2021 -C$1.16 Billion1.68%
2020 -C$1.14 Billion271.17%
2019 -C$0.31 Billion58.99%
2018 -C$0.2 Billion20.89%
2017 -C$0.16 Billion-30.95%
2016 -C$0.24 Billion5.09%
2015 -C$0.22 Billion57.24%
2014 -C$0.14 Billion116.53%
2013 -C$64.41 Million
2011 -C$40.1 Million143.73%
2010 -C$16.46 Million27.85%
2009 -C$12.87 Million0.27%
2008 -C$12.84 Million-20.95%
2007 -C$16.24 Million-13.53%
2006 -C$18.78 Million-10.07%
2005 -C$20.88 Million-21.81%
2004 -C$26.71 Million-33.44%
2003 -C$40.12 Million-6.51%
2002 -C$42.91 Million17.95%
2001 -C$36.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.22 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$91.64 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$76.22 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$48.65 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.30 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France